Bangladesh: Measles Outbreak Vaccine Program Failures Claim 1,000 Lives

• Bangladesh is experiencing a severe measles outbreak, with 999 suspected deaths and over 166,000 suspected cases reported since the beginning of the year.
• The crisis is linked to significant disruptions in the national vaccination program, including interruptions during the COVID-19 pandemic and a missed campaign in 2024.
• Vaccination coverage for the second dose of measles vaccine dropped from 93% in 2024 to 86% last year, falling below the 95% threshold required for herd immunity.
• An emergency vaccination drive was launched in March with support from the WHO, UNICEF, and Gavi to combat the escalating public health emergency.
• The current government attributes the failures in vaccine planning and availability to previous administrations, highlighting governance challenges in public health.

The current government, led by Prime Minister Tarique Rahman, has attributed these systemic failures in planning and vaccine availability to the administrations of ousted Prime Minister Sheikh Hasina and interim leader Muhammad Yunus.

Bangladesh is currently grappling with a severe measles outbreak, which has claimed the lives of nearly 1,000 individuals suspected of having the disease since the beginning of the year. The crisis intensified significantly from March, with over 100 children succumbing to the illness in less than a month. As of Tuesday, September 8, 2026, the government's Directorate General of Health Services reported a total of 999 suspected measles-related deaths.

The human toll of this Bangladesh measles crisis deaths is starkly evident in cases like eight-month-old Rojatun Jannat Ramisa, who struggles for breath in a Dhaka hospital. Her mother, Ranu Akhter, undertook a journey of hundreds of kilometers from eastern Bangladesh to seek specialized treatment, having witnessed the widespread nature of the outbreak firsthand. Akhter observed numerous other children at Dhaka Shishu Hospital exhibiting the characteristic red rashes, mouth sores, and fevers associated with measles, underscoring the pervasive reach of the infection across the nation.

Since March, the Ministry of Health has documented more than 166,000 suspected measles cases, with 19,835 of these confirmed through laboratory testing. In response to this alarming Bangladesh public health emergency, an emergency vaccination drive was initiated in March. This critical effort, a collaboration involving the World Health Organization (WHO Bangladesh vaccine program), the U.N. children’s agency (UNICEF), and the Gavi vaccine alliance, initially targeted children aged six months to five years before expanding nationwide in a phased approach.

For decades, Bangladesh maintained a robust vaccination program, successfully protecting its population, particularly children and mothers, from a range of deadly diseases including tuberculosis, diphtheria, whooping cough, tetanus, poliomyelitis, and measles. This sustained effort had brought measles largely under control, with the country recording a mere 100 to 300 cases annually between 2021 and 2025, a significant reduction from 2,410 cases reported in 2020.

However, in recent years, a series of critical disruptions to the national vaccine program created dangerous gaps in immunity, directly contributing to the current Bangladesh measles outbreak vaccine program failures. The COVID-19 pandemic first interrupted routine vaccination schedules, leading many parents to forgo their children's immunizations during 2021 and 2022. This created a cohort of unvaccinated four and five-year-olds, as noted by Atiqul Islam, a neonatal and child specialist at Bangladesh Shishu Hospital and Institute.

Further exacerbating the situation, the government largely failed to execute a crucial quadrennial vaccination campaign in 2024. Additionally, during the tenure of the previous interim government, many vaccination centers experienced significant unavailability of essential vaccines. These cumulative failures represent a severe measles vaccine disruption Bangladesh, leaving a growing number of children vulnerable to the highly contagious disease.

Measles, an airborne disease, is highly contagious, manifesting with fever, respiratory symptoms, and a distinctive rash. While typically manageable, it can lead to severe or even fatal complications, particularly in young children, as highlighted by the World Health Organization. Effective protection against measles requires two doses of a vaccine.

Crucially, the WHO emphasizes that a vaccination coverage rate of 95% across the population is essential to halt the spread of measles. This high threshold is vital not only for direct protection but also for establishing herd immunity, which safeguards infants too young to be vaccinated and immunocompromised individuals. Bangladesh's vaccination rates have unfortunately fallen below this critical level; an estimate by the WHO and UNICEF indicates that approximately 86% of children received their recommended second dose of the measles vaccine last year, a notable decline from 93% in 2024.

The current government, led by Prime Minister Tarique Rahman, has attributed these systemic failures in planning and vaccine availability to the administrations of ousted Prime Minister Sheikh Hasina and interim leader Muhammad Yunus. This political blame game underscores the governance risks associated with maintaining robust public health infrastructure and emergency preparedness, particularly when national vaccination programs face disruptions.

This article highlights the severe public health and governance risks associated with disruptions to national vaccination programs, offering a critical case study for compliance officers and public health legal advisors on the importance of robust health infrastructure and emergency preparedness to prevent widespread outbreaks and potential state liability.

Source: Original reporting via The Associated Press